Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,599.50
Bid: 1,604.00
Ask: 1,604.50
Change: 4.50 (0.28%)
Spread: 0.50 (0.031%)
Open: 1,600.50
High: 1,612.50
Low: 1,591.00
Prev. Close: 1,595.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS: Panmure Upgrades Shire To Buy From Hold

Thu, 16th Oct 2014 08:36

LONDON (Alliance News) - The following UK shares received analyst recommendations Thursday morning:
----------
FTSE 100
----------
BERENBERG CUTS ROLLS-ROYCE PRICE TARGET TO 1160 (1216) PENCE - 'BUY'
----------
UBS RAISES ANTOFAGASTA TO 'NEUTRAL' ('SELL') - TARGET 710 PENCE
----------
UBS CUTS ANGLO AMERICAN PRICE TARGET TO 1450 (1700) PENCE - 'NEUTRAL'
----------
UBS CUTS BHP BILLITON PRICE TARGET TO 2100 (2300) PENCE - 'BUY'
----------
UBS CUTS RIO TINTO PRICE TARGET TO 3500 (3900) PENCE - 'BUY'
----------
GOLDMAN RAISES RIO TINTO PRICE TARGET TO 2600 (2550) PENCE - 'CONVICTION SELL LIST'
----------
UBS CUTS FRESNILLO PRICE TARGET TO 1000 (1050) PENCE - 'BUY'
----------
BARCLAYS RAISES ASTRAZENECA PRICE TARGET TO 4150 (4100) PENCE - 'EQUAL WEIGHT'
----------
TRADERS: MERRILL LYNCH ADDS ASTRAZENECA TO 'EUROPE 1 LIST'
----------
BARCLAYS CUTS GLAXOSMITHKLINE PRICE TARGET TO 1485 (1500) PENCE - 'EQUAL WEIGHT'
----------
BARCLAYS RAISES SHIRE PRICE TARGET TO 4100 (3900) PENCE - 'OVERWEIGHT'
----------
PANMURE RAISES SHIRE TO 'BUY' ('HOLD') - TARGET 4200 (5300) PENCE
----------
GOLDMAN CUTS BABCOCK INTERNATIONAL PRICE TARGET TO 1380 (1405) PENCE - 'BUY'
----------
CREDIT SUISSE CUTS ARM PRICE TARGET TO 1000 (1100) PENCE - 'OUTPERFORM'
----------
HSBC CUTS WPP PRICE TARGET TO 1540 (1600) PENCE - 'OVERWEIGHT'
----------
TRADERS: NUMIS RAISES WHITBREAD TO 'ADD' ('HOLD')
----------
Numis Cuts Diageo Price Target To 1,800p From 1,900p, Reiterates Hold
----------
FTSE 250
----------
UBS RAISES BELLWAY PRICE TARGET TO 1910 (1870) PENCE - 'BUY'
----------
UBS REMOVES FERREXPO FROM 'LEAST PREFERRED LIST' - 'SELL'
----------
UBS CUTS FERREXPO PRICE TARGET TO 80 (100) PENCE - 'SELL'
----------
UBS CUTS HOCHSCHILD MINING PRICE TARGET TO 135 (185) PENCE - 'NEUTRAL'
----------
UBS CUTS KAZAKHMYS PRICE TARGET TO 340 (370) PENCE - 'BUY'
----------
UBS CUTS LONMIN PRICE TARGET TO 190 (250) PENCE - 'NEUTRAL'
----------
UBS CUTS POLYMETAL PRICE TARGET TO 500 (550) PENCE - 'NEUTRAL'
----------
GOLDMAN CUTS BARRATT DEVELOPMENTS PRICE TARGET TO 499 (530) PENCE - 'BUY'
----------
GOLDMAN RAISES BERKELEY GROUP PRICE TARGET TO 2871 (2870) PENCE - 'NEUTRAL'
----------
Numis Upgrades Bank Of Georgia To Buy From Hold, Price Target 2,708 pence
----------
MAIN MARKET AND AIM
----------
GOLDMAN CUTS ASOS PRICE TARGET TO 3000 (4300) PENCE - 'BUY'
----------
GOLDMAN CUTS SHANKS GROUP PRICE TARGET TO 109 (128) PENCE - 'BUY'
----------
Liberum Raises Game Digital Price Target To 265p From 350p, Buy
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2014 Alliance News Limited. All Rights Reserved.

More News
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
29 Dec 2023 13:01

LONDON MARKET CLOSE: UK equities outclassed by other markets in 2023

(Alliance News) - Stock prices in London closed mixed on Friday, the final trading day of 2023, as the annual returns from UK equities were outshone by international markets.

Read more
20 Dec 2023 13:29

GSK buys rights to Hansoh Pharma antibody-drug conjugate

(Sharecast News) - GSK has agreed to buy the rights to an antibody-drug conjugate (ADC) - HS-20093 - from Chinese biopharmaceutical group Hansoh Pharma.

Read more
19 Dec 2023 15:36

German court quashes CureVac patent after challenge by BioNTech

CureVac shares drop 40%Dispute over intellectual property with BioNTech to continue

*

Read more
18 Dec 2023 17:21

Energy stocks lift UK's FTSE 100, Vodafone shines

Vodafone jumps as Iliad offers to merge Italian units

*

Read more
18 Dec 2023 10:07

GSK's dostarlimab trial in endometrial cancer meets primary endpoint

(Alliance News) - GSK PLC on Monday said a trial of dostarlimab in combination with niraparib for treating endometrial cancer has met its primary endpoint.

Read more
18 Dec 2023 07:55

LONDON BRIEFING: Games Workshop seals Amazon deal for Warhammer 40,000

(Alliance News) - Stocks in London were set to retreat slightly on Monday, in line with equity markets in Asia, at the start of the last week before the Christmas holidays.

Read more
18 Dec 2023 07:18

GSK sees success in Jemperli endometrial cancer trial

(Sharecast News) - GSK released positive headline results from the planned analysis of its trial of Jemperli in endometrial cancer on Monday.

Read more
17 Dec 2023 15:16

PRESS: GSK looks for deals in China as rebuilds relationship

(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China.

Read more
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.